NCT00986687 Oocyte Cryopreservation Comparing Fresh and Vitrified Sibling Oocytes Status COMPLETED Phase N/A
NCT00958009 The Multicenter, Open-label, Single-use Autoinjector Convenience Study Status COMPLETED Phase PHASE3
NCT00925548 STRIDE - STimulating Immune Response In aDvanced brEast Cancer Status TERMINATED Phase PHASE3
NCT00813943 Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status Status COMPLETED Phase PHASE2
NCT00735007 12-week Study to Evaluate RebiSmartâ„¢ Suitability for Self Injection in Relapsing Multiple Sclerosis. Status COMPLETED Phase PHASE3
NCT00719199 Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer Status TERMINATED Phase PHASE1
NCT00702065 A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment Status COMPLETED Phase N/A
NCT00689221 Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status Status COMPLETED Phase PHASE3
NCT00656201 Comparison of Crinone 8% Intravaginal Gel and IM Progesterone Supplementation for In Vitro Fertilization (IVF) Status COMPLETED Phase PHASE4
NCT00646308 Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas Status TERMINATED Phase N/A
NCT00642902 A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS) Status TERMINATED Phase PHASE2
NCT00633529 Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC Status COMPLETED Phase PHASE1
NCT00624338 Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE) Status COMPLETED Phase PHASE2/PHASE3